| 2026-08-14 | 8-K | Form 8-K, Item 8.01 |
| 2026-08-11 | Press release | Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates |
| 2026-08-11 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-11 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-03 | Press release | Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality |
| 2026-07-31 | Press release | Achieve Life Sciences Announced Granting of New Hire Inducement Awards |
| 2026-07-29 | Deck | Achieve Corporate Presentation - July 2026 |
| 2026-07-06 | 8-K | Form 8-K, Item 5.03 |
| 2026-06-29 | Press release | Achieve Life Sciences Joins Russell 2000® Index |
| 2026-06-22 | Press release | Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA |
| 2026-06-08 | Proxy | Definitive proxy statement |
| 2026-06-02 | Press release | Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors |
| 2026-06-02 | Press release | Download as PDF |
| 2026-06-02 | 8-K | Form 8-K, Item 5.02 |
| 2026-05-19 | Press release | Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment |
| 2026-05-19 | Press release | Download as PDF |
| 2026-05-19 | Press release | Download as PDF |
| 2026-05-12 | Press release | Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at |
| 2026-05-12 | Press release | Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates |
| 2026-05-12 | Press release | Download as PDF · Q1 2026 |
| 2026-05-12 | Press release | Download as PDF · Q1 2026 |
| 2026-05-12 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-12 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-05-05 | Press release | Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2 |
| 2026-05-05 | Press release | Download as PDF · Q1 2026 |
| 2026-05-05 | Press release | Download as PDF · Q1 2026 |
| 2026-05-01 | Deck | Achieve Corporate Presentation April 2026 View Presentation |
| 2026-04-30 | 10-K | Annual report on Form 10-K/A, FY25 |
| 2026-04-16 | Press release | Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Di |
| 2026-04-16 | 8-K | Form 8-K, Item 1.01 |
| 2026-03-24 | Press release | Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates |
| 2026-03-24 | 8-K | Form 8-K, Item 2.02 results |
| 2026-03-24 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-03-17 | Press release | Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webca |
| 2025-11-06 | Press release | Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program |
| 2025-11-06 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-06 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-07 | 8-K | Form 8-K, Item 5.02 |
| 2025-09-11 | 8-K | Form 8-K, Item 5.02 |
| 2025-08-07 | Press release | Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program |